Inventor · disambiguated record
Imad Nashashibi
Also filed as: NASHASHIBI IMAD · NASHASHIBI IMAD FAYEK
15 granted patents·8 pending applications·102 citations·filing 2005–2017
92Inventor score
Top patents by PatentIndex Score
23 records- 0196US7638541B25-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineMETABOLEX INC·Filed 2007·Granted Dec 29, 2009·43 cites·2 claims
- 0293US8476308B2GPR120 receptor agonists and uses thereofMETABOLEX INC·Filed 2012·Granted Jul 2, 2013·12 cites·6 claims
- 0391US8227495B22,4-disubsituted thiazoles and pharmaceutical compositions thereofCHEN XIN·Filed 2009·Granted Jul 24, 2012·13 cites·18 claims
- 0489US8288384B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2009·Granted Oct 16, 2012·9 cites·1 claims
- 0586US8183381B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2008·Granted May 22, 2012·13 cites·10 claims
- 0684US8598374B2GPR120 receptor agonists and uses thereofMETABOLEX INC·Filed 2012·Granted Dec 3, 2013·6 cites·9 claims
- 0784US8299117B2GPR120 receptor agonists and uses thereofSHI DONG FANG·Filed 2010·Granted Oct 30, 2012·5 cites·6 claims
- 0878US9737537B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·1 cites·2 claims
- 0967US9925189B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2017·Granted Mar 27, 2018·0 cites·2 claims
- 1065US8309600B2GPR120 receptor agonists and uses thereofSHI DONG FANG·Filed 2009·Granted Nov 13, 2012·0 cites·15 claims
- 1164US8921350B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·0 cites·4 claims
- 1261US8975258B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2012·Granted Mar 10, 2015·0 cites·22 claims
- 1356US2014121246A1Gpr120 receptor agonists and uses thereofMETABOLEX INC·Filed 2013·Application pending·0 cites
- 1456US2015239881A1Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2015·Application pending·0 cites
- 1552US2010216827A1Aryl gpr120 receptor agonists and uses thereofMETABOLEX INC·Filed 2009·Application pending·0 cites
- 1650US2011294836A1Aryl gpr119 agonists and uses thereofSONG JIANGAO·Filed 2009·Application pending·0 cites
- 1747US8846675B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2012·Granted Sep 30, 2014·0 cites·22 claims
- 1843US2005288299A1Azaindole derivatives as inhibitors of p38 kinaseMAVUNKEL BABU J·Filed 2005·Application pending·0 cites
- 1940US9593109B2Bicyclic agonists of GPR131 and uses thereofSONG JIANGAO·Filed 2012·Granted Mar 14, 2017·0 cites·20 claims
- 2040US2011313160A1Preparation of 5-ethyl-2--pyrimidineCHEN XIN·Filed 2011·Application pending·0 cites
- 2140US2006199821A1Heterocyclic amides and sulfonamidesSCIOS INC·Filed 2005·Application pending·0 cites
- 2237US8703776B2Agonists of GPR131 and uses thereofNOVACK AARON ROBERT·Filed 2012·Granted Apr 22, 2014·0 cites·20 claims
- 2336US2012184572A1Aryl gpr119 agonists and uses thereofSONG JIANGAO·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Imad Nashashibi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →